Mesoblast
MESO
$7.35
Share price
4.70%
Change (1 day)
91.91%
Change (1 year)
Categories
Earnings for Mesoblast (MESO)
Earnings in 2023 (TTM): -$82.11 M
According to Mesoblast 's latest financial reports the company's current earnings (TTM) are -$82.11 M. In 2022 the company made an earning of -$84.35 M an increase over its 2021 earnings that were of -$97.47 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Mesoblast from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$82.11 M | -2.67% |
| 2022 | -$84.35 M | -13.46% |
| 2021 | -$97.47 M | -6.26% |
| 2020 | -$0.11 B | 21.83% |
| 2019 | -$85.35 M | -9.3% |
| 2018 | -$94.1 M | 47.73% |
| 2017 | -$63.7 M | -37.2% |
| 2016 | -$0.11 B | -8.99% |
| 2015 | -$0.12 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.17 M | -97.37% | Bahamas |
 NRC Health
NRC | $40.82 M | -149.72% | 🇺🇸 USA |